DISC-1459
DISC-1459-201
Phase 3 small_molecule active
Quick answer
DISC-1459 for Erythropoietic Protoporphyria is a Phase 3 program (small_molecule) at Disc Medicine with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Erythropoietic Protoporphyria
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active